PODEXIL

This brand name is authorized in Nigeria.

Active ingredients

The drug PODEXIL contains one active pharmaceutical ingredient (API):

1	Cefpodoxime UNII 2TB00A1Z7N - CEFPODOXIME PROXETIL
	Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins.
	Read more about Cefpodoxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7808	Powder for suspension	PODEXIL POWDER FOR ORAL SUSPENSION PWD_F_SOL 100 mg/5 mL 50ML10,100ML10	PODEXIL POWDER FOR ORAL SUSPENSION CEFPODOXIME PROXETIL USP EQV TO CEFPODOXIME 100MG/5ML Cefpodoxime Proxetil USP 100mg, Xanthan Gum BP, Sodium Benzoate BP, Sucrose (Pharma grade sugar) BP, Additional Sugar BP, Colloidal Silicon Dioxide BP, Aspartame BP, Sodium Saccharin BP, Citric Acid Anhydrous BP, Sodium Citrate BP, Trusil Orange Flavour IH, Trusil Lemon Flavour IH, Lake of sunset Yellow B4-7808 Drugs Imported Products 50ML10,100ML10 POM 1 15/12/2022 STADARD GENERICE LTD, ABOR CLOSE, OFF FOLA AGORO ST, YABA LAGOS LAGOS 12799144 stdgenerics@yahoo.com INNOVA CAPTAB PVT LTD, 1281/1, HILLTOP INDUSTRIAL ESTATE, NEAR EPIP PHASE -1 BADDI (H.P.) INDIA PIN-173205, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD13	Cefpodoxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7808